AnaptysBio (ANAB) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free ANAB Stock Alerts $25.47 -0.13 (-0.51%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AnaptysBio Stock Price Performance5 Day Performance+8.63%1 Month Performance+19.17%3 Month Performance+5.52%6 Month Performance+78.33%Year-To-Date Performance+18.72%1 Year Performance+36.50% Receive ANAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. ANAB Stock Chart for Thursday, May, 16, 2024 ANAB Chart by TradingView AnaptysBio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$25.26$25.60+1.35%$26.22$25.22216,016 shs$699.39 million05/14/2024$23.99$25.26+5.29%$25.44$24.09272,554 shs$690.10 million05/13/2024$23.41$23.99+2.48%$24.70$23.41433,285 shs$655.41 million05/10/2024$26.23$23.41-10.75%$26.14$23.23325,459 shs$639.54 million05/09/2024$25.75$26.23+1.86%$26.58$25.37226,328 shs$716.58 million05/08/2024$25.68$25.75+0.27%$26.01$25.23235,121 shs$703.49 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$25.77$25.68-0.35%$26.50$25.17320,769 shs$701.58 million05/06/2024$26.58$25.77-3.05%$26.63$25.29195,199 shs$704.04 million05/03/2024$26.34$26.58+0.91%$27.02$25.64331,954 shs$726.17 million05/02/2024$26.02$26.34+1.23%$26.74$24.75322,320 shs$719.61 million05/01/2024$24.34$26.02+6.90%$26.35$24.38794,807 shs$710.87 million04/30/2024$21.30$24.34+14.27%$24.50$21.031.10 million shs$664.97 million04/29/2024$21.00$21.30+1.43%$22.74$21.02719,618 shs$581.92 million04/26/2024$18.87$21.00+11.29%$21.61$18.72649,169 shs$561.96 million04/25/2024$19.27$18.87-2.08%$19.30$18.49400,998 shs$504.96 million04/24/2024$19.18$19.27+0.47%$19.29$18.71385,671 shs$515.67 million04/23/2024$19.66$19.18-2.44%$20.48$19.17387,321 shs$513.26 million04/22/2024$19.87$19.66-1.06%$20.27$19.60139,694 shs$526.10 million04/19/2024$19.83$19.87+0.20%$20.66$19.08288,943 shs$531.72 million04/18/2024$21.47$19.83-7.64%$21.78$19.79363,855 shs$530.65 million04/17/2024$21.34$21.47+0.61%$21.56$20.83297,067 shs$574.54 million04/16/2024$21.27$21.34+0.33%$22.15$21.03244,875 shs$571.06 million04/15/2024$22.71$21.27-6.34%$23.10$21.07267,275 shs$569.19 million04/12/2024$24.73$22.71-8.17%$24.94$22.53347,661 shs$607.72 million04/11/2024$22.17$24.73+11.55%$25.62$23.86572,973 shs$661.85 million04/10/2024$21.53$22.17+2.97%$22.43$20.71349,285 shs$593.34 million04/09/2024$20.67$21.53+4.16%$21.82$20.38423,137 shs$576.14 million04/08/2024$21.08$20.67-1.94%$21.50$20.67120,633 shs$553.13 million04/05/2024$21.30$21.08-1.03%$21.49$20.80134,088 shs$564.10 million04/04/2024$20.72$21.30+2.80%$22.00$20.65392,760 shs$569.99 million04/03/2024$20.84$20.72-0.58%$20.92$20.27523,555 shs$554.47 million04/02/2024$21.32$20.84-2.25%$21.03$20.40454,697 shs$557.68 million04/01/2024$22.52$21.32-5.33%$22.55$20.46642,525 shs$570.52 million03/29/2024$22.52$22.52$22.87$20.82470,804 shs$602.64 million03/28/2024$21.38$22.52+5.33%$22.87$20.82470,804 shs$602.64 million03/27/2024$21.60$21.38-1.02%$21.83$20.98388,039 shs$572.13 million03/26/2024$21.10$21.60+2.37%$21.85$20.70420,718 shs$578.02 million03/25/2024$21.67$21.10-2.63%$22.01$21.05402,984 shs$579.95 million03/22/2024$24.45$21.67-11.37%$24.45$21.60541,506 shs$579.89 million03/21/2024$23.94$24.45+2.13%$24.71$24.02414,344 shs$654.28 millionThis is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects03/20/2024$23.27$23.94+2.88%$24.00$22.73408,998 shs$640.63 million03/19/2024$23.17$23.27+0.43%$23.46$22.79347,102 shs$622.71 million03/18/2024$23.45$23.17-1.19%$23.54$22.52378,388 shs$620.03 million03/15/2024$23.60$23.45-0.64%$24.41$23.321.36 million shs$627.52 million03/14/2024$24.69$23.60-4.41%$24.49$23.23369,762 shs$627.29 million03/13/2024$26.06$24.69-5.26%$26.34$24.67345,392 shs$656.26 million03/12/2024$23.35$26.06+11.61%$27.00$24.55528,424 shs$692.68 million03/11/2024$24.80$23.35-5.85%$24.95$23.34316,369 shs$620.53 million03/08/2024$24.63$24.80+0.69%$25.48$24.29106,408 shs$659.18 million03/07/2024$25.49$24.63-3.37%$25.64$24.60141,510 shs$654.67 million03/06/2024$25.33$25.49+0.63%$25.78$25.16269,837 shs$677.52 million03/05/2024$26.15$25.33-3.14%$26.33$24.67175,374 shs$673.27 million03/04/2024$25.45$26.15+2.75%$26.90$24.94265,176 shs$695.07 million03/01/2024$25.53$25.45-0.31%$26.00$25.28193,898 shs$676.46 million02/29/2024$25.81$25.53-1.08%$26.45$25.31180,144 shs$678.59 million02/28/2024$26.47$25.81-2.49%$26.59$25.59198,718 shs$686.03 million02/27/2024$26.46$26.47+0.04%$26.85$26.22150,221 shs$703.57 million02/26/2024$25.87$26.46+2.28%$27.48$26.02308,742 shs$703.17 million02/23/2024$25.28$25.87+2.33%$26.12$25.11231,675 shs$687.63 million02/22/2024$25.49$25.28-0.82%$25.88$24.87229,561 shs$671.94 million02/21/2024$23.83$25.49+6.97%$25.67$24.49348,773 shs$677.52 million02/20/2024$24.10$23.83-1.12%$24.59$23.52193,913 shs$633.40 million02/19/2024$24.10$24.10$25.04$23.45598,000 shs$640.58 million02/16/2024$22.76$24.10+5.89%$25.04$23.45598,088 shs$640.46 million02/15/2024$22.29$22.76+2.11%$22.80$22.2392,770 shs$604.96 million Related Companies: CureVac Stock Chart Cogent Biosciences Stock Chart GH Research Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Wave Life Sciences Stock Chart Nuvation Bio Stock Chart Sage Therapeutics Stock Chart Pharming Group Stock Chart Mineralys Therapeutics Stock Chart Lyell Immunopharma Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.